Ann Kramer
Ann Kramer has over 20 years international general management and business development experience with blue chip and SME companies in bioscience, sustainability and agribusiness.
Business strategy, analysis and planning
* Wrote fund-raising business plan for Microbial Solutions Ltd (RFL)
* Wrote third round business plan that raised £1.5 m (Oxitec)
* Rationalised post-merger food biotechnology project portfolio (SYT)
* Analysed potential for novel GM enzymes in biofuel and feed (SYT)
* Evolved strategy to focus on public health and to enter Brazil (Oxitec)
Transactions led
* Sponsored research contract with multinational (Oxitec)
* Acquisition of herbicide-tolerant technology from Bayer (SYT)
* Divestment of cotton seed company (SYT)
* R&D collaboration with major branded food company (ZPS)
* US federal government negotiations (Oxitec)
Business Development
* Opened market development for GM mosquitoes in Brazil, USA, Panama, Singapore, other (Oxitec)
* Set up and managed food co. alliances to develop novel products (SYT)
* Successful grant applications/ extensions to Wellcome Foundation, Gates Foundation, TSB, EU (Oxitec, Immunocore)
CV
Chief Operating Officer at Immunocore Ltd. (2010-11)
Head of Business Development at Oxitec Ltd. (2006-10)
Manager in M&A group at Syngenta AG. (2002-06)
Business Manager of Food Biotechnology at Zeneca/Syngenta (1996-2001)
Tech sales, strategic analyst, marketing support, field research (1988-95)
